Achieving Rapid, Safe and Sustained Glucose Control in Adolescents With Suboptimally Controlled Type 1 Diabetes Using Advanced Hybrid Closed Loop Systems - Trial NCT06305377
Access comprehensive clinical trial information for NCT06305377 through Pure Global AI's free database. This phase not specified trial is sponsored by Giulio Frontino and is currently Not yet recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Giulio Frontino
IRCCS San Raffaele
Timeline & Enrollment
N/A
Mar 11, 2024
Mar 30, 2024
Primary Outcome
Glucometric data
Summary
The rational of this study is to assess if AHCL systems are able to achieve a better
 metabolic control (better glucometric data) after 2 weeks, 1 months. 6 months and 1 year
 after the start, in adolescents in not good glycaemic control.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06305377
Device Trial